A Pilot Study of a Hedgehog Pathway Inhibitor (LDE-225) in Surgically Resectable Pancreas Cancer
- Status
- WITHDRAWN
- Phase
- EARLY_PHASE1
Clinical Trials Related to Novartis Pharmaceuticals
Related studies linked through entity extraction aliases.
Safety and Efficacy of BKM120 in Relapsed and Refractory NHL
- Status
- COMPLETED
- Phase
- PHASE2
Study of the Safety and Efficacy of LCZ696 on Arterial Stiffness in Elderly Patients With Hypertension
- Status
- COMPLETED
- Phase
- PHASE2
Drug-drug Interaction Study of Ofatumumab With Bendamustine in Subjects With Indolent B-cell Non-Hodgkin's Lymphoma
- Status
- COMPLETED
- Phase
- PHASE1
A Phase II Study of Orally Administered BEZ235 Monotherapy in Patients With Metastatic or Unresectable Malignant PEComa
- Status
- WITHDRAWN
- Phase
- PHASE2
Safety, Efficacy and PK/PD of QGE031 vs. Placebo in Patients With Active Bullous Pemphigoid Despite Oral Steroid Treatment
- Status
- TERMINATED
- Phase
- PHASE2
Vildagliptin vs Sitagliptin add-on to Insulin - Impact on Glycemic Profile and Correlation of Hypoglycemic Episodes and Heart Function
- Status
- COMPLETED
- Phase
- PHASE4
Cross-Sectional Iloperidone IVGTT
- Status
- COMPLETED
- Phase
- N/A
LDK378 in Crizotinib naïve Adult Patients With ALK-activated Non-small Cell Lung Cancer
- Status
- COMPLETED
- Phase
- PHASE2
LDK378 in Adult Patients With ALK-activated NSCLC Previously Treated With Chemotherapy and Crizotinib
- Status
- COMPLETED
- Phase
- PHASE2
A Multi-centre Randomized Double Blind 52-week Study to Assess the Safety of QVA149 Compared to QAB149 in Patients With COPD Who Have Moderate to Severe Airflow Limitation
- Status
- COMPLETED
- Phase
- PHASE3
Dabrafenib With Trametinib in the Adjuvant Treatment of High-risk BRAF V600 Mutation-positive Melanoma (COMBI-AD).
- Status
- COMPLETED
- Phase
- PHASE3
Assessment of LCZ696 and Valsartan in Asian Patients With Salt-sensitive Hypertension
- Status
- COMPLETED
- Phase
- PHASE2
Dovitinib Combined With Bortezomib and Dexamethasone for Relapsed/Refractory Multiple Myeloma
- Status
- WITHDRAWN
- Phase
- PHASE1
A Phase II Study of Dovitinib in Recurrent and/or Metastatic Adenoid Cystic Carcinoma of the Salivary Glands
- Status
- COMPLETED
- Phase
- PHASE2
A Study to Determine Safety, Tolerability and Pharmacokinetics of Oral Dabrafenib In Children and Adolescent Subjects
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
An Open-label, Multi-arm, Non-comparative Safety and Tolerability Study of Canakinumab (ACZ885) in Patients With Active Systemic Juvenile Idiopathic Arthritis (SJIA)
- Status
- WITHDRAWN
- Phase
- PHASE3
Efficacy and Safety of Pasireotide LAR (Long-acting Release) in Japanese Patients With Acromegaly or Pituitary Gigantism
- Status
- COMPLETED
- Phase
- PHASE2
BYM338 in Chronic Obstructive Pulmonary Disease (COPD) Patients With Cachexia
- Status
- COMPLETED
- Phase
- PHASE2
Maintenance Rituximab With mTor Inhibition After High-dose Consolidative Therapy in Lymphoma
- Status
- COMPLETED
- Phase
- PHASE2